NCT06049693View on ClinicalTrials.gov

Iron Prehabilitation in Endometrial Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Endometrial CancerPerioperative ComplicationPrehabilitation
Interventions
DRUG

Ferrous Gluconate 300 MG

Ferrous Gluconate 300 MG twice a day

Trial Locations (1)

11523

First department of Obstetrics and Gynecology, Athens

All Listed Sponsors
lead

National and Kapodistrian University of Athens

OTHER